NNPTE
RVMD icon

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne’s Revolution Medicines RVMD Stock Holding History

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$89.7M Hold
479,080
– – 4.91% 6
2026
Q1 		$46.6M Buy
+479,080
New +$48.4M 3.95% 7

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's RVMD Position: Q2 2026 in Review

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne held its Revolution Medicines (RVMD) position steady in Q2 2026 at 479,080 shares worth $89.7M. The position accounts for 4.91% of the portfolio, ranked #6.

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in RVMD in Q1 2026 and has held it in 2 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne held 479,080 shares of Revolution Medicines worth $89.7M as of Q2 2026.
  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne left its Revolution Medicines share count unchanged in Q2 2026.
  • Revolution Medicines made up 4.91% of Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's portfolio in Q2 2026, its #6 holding.
  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in Revolution Medicines in Q1 2026 and has held it in 2 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's 13F filing for Q2 2026, filed 7 Aug 2026.